TN Drug Control Dept to hold quarterly meet with pharma trade, consumer bodies
• The Drugs Control Department of Tamil Nadu will be holding interactive meetings quarterly with the pharma traders and consumer organisations in the state. A decision in this regard was taken by the Directorate last week, said the DC
DCGI to convene Drugs Consultative Committee meeting on June 29
• The Drug Controller General of India (DCGI) will convene the next Drugs Consultative Committee (DCC) meeting on June 29 which is expected to discuss several important issues which have been pending for some time.
• Last DCC meeting was convened on December 10 last year in which several crucial decisions were taken including the decision to phase out Artemisinin, the drug used as monotherapy to treat multi-drug resistant strains of falciparum malaria, from the Indian market.
• The meeting, which will be the 40th DCC meeting, is likely to discuss important issues like regulation on medical devices, regulation on Clinical Research Organisations (CROs) and the progress in resolving the FDC issue.
• Another major issue what will be raised in the meeting is the regulation on CROs. At present, the state drug authorities give licences to the CROs under Form 29. They have no powers to oversee the functioning of the CROs. The state authorities will seek clarity about their role in regulating the CROs in their respective states.
• The meeting will also discuss the issue of medication devices regulation.
